Effect of vasoactive intestinal peptide in man.
Krejs
G J
GJ
Department of Internal Medicine, Karl-Franzens-University School of Medicine, Graz, Austria.
D007516:Adenoma, Islet Cell / Q000503:physiopathology*; D002319:Cardiovascular System / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D010190:Pancreatic Neoplasms / Q000503:physiopathology*; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000502:physiology*; D003969:Vipoma / Q000503:physiopathology*
D014660:Vasoactive Intestinal Peptide